First, we found that alpelisib treatment keeps PI3K-AKT signaling pathway activity suppressed during Influenza A infection in MDCK-London cells (Fig. 3), counteracting influenza’s upregulation of PI3K signaling (Fig. 2; [8, 32,]. Here, AKT1 is linked to influenza.